Louisville, Colorado, June 12, 2025 (GLOBE NEWSWIRE) -- CEA Industries Inc. (NASDAQ: CEAD, CEADW) (“CEA Industries” or the “Company”), today announced that it will change its ticker symbol on the NASDAQ Capital Market from "CEAD" to "VAPE." This change is expected to take effect at the opening of trading on Friday, June 13, 2025. The new ticker symbol "VAPE" reflects the Company's strategic focus on the rapidly growing vaping industry, following its recent acquisition of Fat Panda, a leading Canadian vape r ...

FREDERICK, Md., June 12, 2025 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today is proud to announce it has been honored with the prestigious "Disinfection and Decontamination Products Company of the Year 2025" award by MedTech Outlook. This recognition highlights TOMI’s unwavering commitment to excellence and the strong confidence customers and industry peers have in its SteraMist iHP technolog ...

Partnership Expands Capital Access to Support Development of Solar, Battery, Microgrid, and Wireless EV Charging Projects within NextNRG’s National PipelineMIAMI, June 12, 2025 (GLOBE NEWSWIRE) -- NextNRG, Inc. (NASDAQ: NXXT), a pioneer in AI-driven energy solutions revolutionizing production, management, and delivery with the Next Utility Operating System®, smart microgrids, wireless EV charging, and on-demand mobile fuel, today announced a strategic partnership with Hudson Sustainable Group LLC, one of th ...

Core Viewpoint - Saratoga Investment Corp. has declared a base quarterly dividend of $0.75 per share for the second quarter of fiscal 2026, continuing its strong dividend distribution history and providing a 12.5% dividend yield based on its recent stock price of $24.08 per share [1][2]. Dividend Declaration - The declared dividends for the second quarter of fiscal 2026 are as follows: - June 2025: $0.25 per share, record date July 8, 2025, payment date July 24, 2025 - July 2025: $0.25 per share, record date August 6, 2025, payment date August 21, 2025 - August 2025: $0.25 per share, record date September 4, 2025, payment date September 24, 2025 [1]. Historical Dividend Distributions - The total dividend for fiscal year 2026 is projected to be $1.50 per share, with consistent monthly dividends of $0.25 per share since fiscal Q1 2026 [3]. - Historical dividends per share for previous fiscal years include: - Fiscal 2025: $2.96 total, with quarterly distributions of $0.74 - Fiscal 2024: $2.86 total, with quarterly distributions of $0.71 to $0.73 - Fiscal 2023: $2.44 total, with quarterly distributions ranging from $0.53 to $0.69 [3]. Company Overview - Saratoga Investment is a specialty finance company focused on providing customized financing solutions to U.S. middle-market businesses, primarily through senior and unitranche leveraged loans and mezzanine debt [4]. - The company aims to generate attractive risk-adjusted returns through current income and long-term capital appreciation from its investments [4]. - Saratoga Investment is regulated as a business development company and is externally managed by Saratoga Investment Advisors, LLC [4].

GAITHERSBURG, Md., June 12, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), announces that its Board of Directors have approved a proposed reverse stock split of its common stock at a ratio of 25-for-1. The proposed action remains subject to approval by Nasdaq and, if approved, the Company ...

Patent portfolio now includes protection for manufacture, methods and compositions Provides AIM with patent protection for manufacturing Ampligen until 2041 OCALA, Fla., June 12, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (OTC Pink: AIMID) (“AIM” or the “Company”) today announced the United States Patent and Trademark Office has granted U.S. patent No. 12312376, titled “Therapeutic Double Stranded RNA and Methods for Producing the Same.” The patent expires January 25, 2041. The new pa ...

VANCOUVER, British Columbia, June 12, 2025 (GLOBE NEWSWIRE) -- BIGG Digital Assets Inc. (“BIGG” or the “Company”)(TSXV: BIGG; OTCQX: BBKCF; WKN: A2PS9W), a leading innovator in the digital assets space and owner of TerraZero, Netcoins and Blockchain Intelligence Group, is pleased to announce the official launch of AI integration into Intraverse, TerraZero’s immersive social gaming technology platform. This marks the debut of “Gigi”, the platform’s new AI guide, designed to help users explore, interact, and ...

VANCOUVER, British Columbia, June 12, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence (AI)-powered drug discovery, is pleased to announce that members of its executive team will attend the 2025 BIO International Convention, taking place June 16th – 19th in Boston, Massachusetts. Rakovina Therapeutics’ management will participate in one-on-one partnering ...

SINGAPORE, June 12, 2025 (GLOBE NEWSWIRE) -- GCL Global Holdings Ltd. (NASDAQ: GCL) (“GCL” or the “Company”), a leading provider of games and entertainment, today announced that the Company will be participating in an upcoming tech-focused webinar series hosted by Webull on June 20th. Webull Tech Week Corporate Webinar Series Presentation format with Q&A to follow Who: Sebastian Toke, Group CEOWhen: June 20, 2025, 2:00pm – 3:00pm EasternWhere: Virtual - Register Here About GCL Global Holdings GCL Global Hol ...

Models provide highly relevant species-specific data, predict in vivo drug clearance/transport, and support preclinical analysis of cancer therapiesPITTSBURGH, June 12, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, announced today the company has successfully developed 3D organoid models exclusively for Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services. As part of an ongoing agreement, Predictive Oncology recentl ...